- Home
- SYRE vs DSGX Comparison
SYRE vs DSGX Comparison
Compare SYRE & DSGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | DSGX |
|---|---|---|
| Founded | 2013 | 1981 |
| Country | United States | Canada |
| Employees | 112 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.2B |
| IPO Year | 2015 | 1999 |
Fundamental Metrics
Financial Performance| Metric | SYRE | DSGX |
|---|---|---|
| Price | $73.58 | $71.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $85.08 | ★ $105.22 |
| AVG Volume (30 Days) | ★ 927.8K | 390.5K |
| Earning Date | 05-08-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.05 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.93 | $62.56 |
| 52 Week High | $78.80 | $117.35 |
Technical Indicators
Market Signals| Indicator | SYRE | DSGX |
|---|---|---|
| Relative Strength Index (RSI) | 57.09 | 51.30 |
| Support Level | $67.18 | $69.44 |
| Resistance Level | $76.16 | $75.06 |
| Average True Range (ATR) | 4.12 | 2.55 |
| MACD | -0.97 | 0.13 |
| Stochastic Oscillator | 62.77 | 60.31 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.